Respiratory Virus Infection Drugs Market a value of US$ 82.4 Bn by the end of 2030
Intelligent AI, ML Algorithms Supporting COVID-19 Molecular Applications The AI (Artificial Intelligence)-driven COVID-19 drug discovery is gaining increased popularity in the respiratory virus infection drugs …